RxDoctor Payments Data

Michael McDonald, PA

Physician Assistant · Middletown, CTNPI 1265413793

Payments from drug & device makers

$4,127in general payments, 2019–2025

Across 212 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$889
  • Takeda Pharmaceuticals U.S.A., Inc.$383
  • Johnson & Johnson$275
  • Ardelyx, Inc.$221
  • Bristol Myers Squibb$188
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$4,02798%
  • Education$170%
  • Other$822%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,127 in reported general payments places this provider in the 90th percentile of 1,795 physician assistant providers in Connecticut.

See all physician assistant providers in Connecticut

Medicare billing

Part B allowed, 2024
$55,699
Medicare patients
389
Services billed
603

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase68$164,920
Humira PenAdalimumab12$79,147
LinzessLinaclotide97$74,510
ZenpepLipase/Protease/Amylase23$63,659
XifaxanRifaximin11$24,385
ViberziEluxadoline15$22,844
Mesalamine25$19,866
Dexlansoprazole DrDexlansoprazole36$13,626
Mesalamine DrMesalamine16$6,106
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates88$4,988
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C32$4,558
Omeprazole236$4,249
ClenpiqSod Picosulf/Mag Ox/Citric Ac24$4,086
Pantoprazole Sodium270$3,598
Ursodiol11$2,461

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess, Viberzi$1,048$262,275180 claims
Aimmune Therapeutics, Inc.Zenpep$33$63,65923 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Plenvu$889$28,94343 claims
Ferring Pharmaceuticals Inc.Clenpiq$28$4,08624 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,795 physician assistant providers in Connecticut.

Other physician assistant in Middletown

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →